GPLGIAGQ Pep-LNP
Cat. No.: TDLD-0126-LD94
GPLGIAGQ Pep-LNP
GPLGIAGQ Pep-LNP is a peptide-functionalized lipid nanoparticle (LNP) engineered with the GPLGIAGQ peptide, enabling targeted delivery by binding to specific receptors, offering enhanced biocompatibility and reduced non-specific interactions for therapeutic cargoes. Please note that this product is intended for research purposes only.
Inquiry
SPECIFIC INQUIRY
Clear All
For Research Use Only. Not for Diagnostic or Treatment Applications.
| Payload Type | mRNA |
| Payload | Empty; EGFP mRNA; Firefly Luciferase mRNA; mCherry mRNA; GFP mRNA; OVA mRNA; EPO mRNA; Renilla Luciferase mRNA; Gaussia Luciferase mRNA; Beta-galactosidase mRNA; Cre mRNA; mOrange mRNA; tdTomato mRNA; EYFP mRNA; Others |
| Capping | Cap 1 |
| Modification | Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other |
| Module Type | Peptide |
| Targeting Module | GPLGIAGQ Peptide |
| Target | Tumor |
| Lipid Formulation | DLin-MC3-DMA; LP-01; ALC-0315; SM102; Other |
| Dye | Unlabeled; DiR; DiD; DiO; DiI; Other |
| Application | Control; Targeted Delivery; Gene Therapy |
| Format | Liquid |
| Concentration | 0.1 mg/mL; 0.2 mg/mL; Other (Please Specify) |
| Size | 65-120 nm |
| PDI | < 0.2 |
| Zeta | ± 20.0 mV |
| Encapsulate Efficiency | >90% |
| Shipping | Dry Ice |
| Storage | Store at -80°C |
Related Products
CSNRDARRC Pep-LNP (TDLD-0126-LD77)
c(RGDyK) Pep-LNP (TDLD-0126-LD74)
THRPPMWSPVWP Pep-LNP (TDLD-0126-LD142)
VHPKQHRC Pep-LNP (TDLD-0126-LD148)
ADH1 Pep-LNP (TDLD-0126-LD60)
CCK8 Pep-LNP (TDLD-0825-LD105)
NGR Pep-LNP (TDLD-0825-LD77)
EPO mRNA-LNP (TDLD-0825-LD14)
Online Inquiry
